GSK is a global biopharma company with the ambition and purpose to unite science, technology and talent to get ahead of disease together.   I’m very excited to be posting multiple full-time permanent opportunities for talented individuals to join us in the UK Structural Biology and Biophysics group based in Stevenage as we expand …

The Northeastern Collaborative Access Team (NE-CAT), located at the Advanced Photon Source at the Argonne National Laboratory in suburban Chicago, is seeking applicants for a Staff Scientist position at the Research Associate and Sr. Research Associate levels.  Primary responsibilities will be to provide training and support to users of NE-CAT’s two state-of-the-art X-ray beamlines, provide …

Dear all,  I would be grateful if you would please circulate the below PhD opportunity to potential candidates in your network. Many thanks. Wyatt Yue Professor of Structural Biology Biosciences Institute Newcastle University NE2 4HH Profile: wyattyue.github.io CRISPR-mediated tagging of endogenous proteins for structural mapping of interactions A 4-year fully-funded PhD position is available in Wyatt …

Dear All   We are looking for two postdocs with expertise in structural biology to join our research group in the Centre for Structural Biology at Queen Mary University of London. These Wellcome Trust funded posts will work towards understanding the molecular mechanism of DNA replication initiation in bacteria. This structural biology project will take …

Converted from text/plain format Posted on behalf of Jochen Küpper. ————————————————————————————————————————————— Dear Colleagues, My group has multiple openings to work on a novel approach for sample preparation in high-resolution cryo-electron microscopy for structural biology. This project is in collaboration with partners at the Center for Structural Systems Biology (CSSB) in Hamburg and from the cryo-EM …

Dear Colleagues.   Still six days to apply for an exciting opening in our group for a postdoc to work on characterisation of new plastic degrading enzymes (“plastizymes”) in a BBSRC-funded sLoLa project lead by Florian Hollfelder and in collaboration with Christine Orengo (UCL) and Rob Finn (EMBL-EBI).   We are looking for someone with …

Postdoctoral positions – structural mechanisms of genome maintenance Vanderbilt University   Description Multiple NIH-funded postdoctoral positions are available in the laboratory of Dr. Brandt Eichman at Vanderbilt University to study molecular mechanisms of enzymes involved in DNA replication-repair. Projects include (1) repair and tolerance of DNA damage during replication, (2) resolution of stalled replication forks, …

[if gte mso 9]> Normal 0 false false false en-CH X-NONE HE /* Style Definitions */ table.MsoNormalTable {mso-style-name:”Table Normal”; mso-tstyle-rowband-size:0; mso-tstyle-colband-size:0; mso-style-noshow:yes; mso-style-priority:99; mso-style-parent:””; mso-padding-alt:0cm 5.4pt 0cm 5.4pt; mso-para-margin-top:0cm; mso-para-margin-right:0cm; mso-para-margin-bottom:8.0pt; mso-para-margin-left:0cm; line-height:107%; mso-pagination:widow-orphan; font-size:11.0pt; font-family:”Calibri”,sans-serif; mso-ascii-font-family:Calibri; mso-ascii-theme-font:minor-latin; mso-hansi-font-family:Calibri; mso-hansi-theme-font:minor-latin; mso-bidi-font-family:Arial; mso-bidi-theme-font:minor-bidi; mso-bidi-language:HE;} <![endif] StartFragment Open Positions: Multiple Ph.D. and postdoctoral positions are available in …

Converted from text/plain format The application deadline for our MSCA Doctoral Network BiodeCCodiNNg (https://biodeccodinng.eu) has been extended until January 31! We seek talented individuals to join our team and conduct cutting-edge research on enzymes catalyzing C-C and N-N bond formations and their applications in biocatalytic syntheses. We especially encourage students interested in structural enzymology, bioinformatics, …

Dear all,We are currently seeking a motivated Protein Crystallographer to join the Structural Sciences group at CHARM Therapeutics (Cambridge, UK). CHARM Therapeutics is a biotech company focused on delivering transformational medicines that will address difficult-to-drug targets in key oncogenic pathways. CHARM has developed the first highly accurate, high throughput protein-ligand co-folding algorithm (DragonFold), driven by …